About
Investor & Media Contact:
Lumos Pharma Investor Relations
512-792-5454
ir@lumos-pharma.com
Source:
Source:
2022 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | -0.99% | +8.33% | -5.97% |
07/03 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
07/03 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
About
Investor & Media Contact:
Lumos Pharma Investor Relations
512-792-5454
ir@lumos-pharma.com
Source:
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-5.97% | 24.51M | |
+28.91% | 42.68B | |
-3.14% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.20% | 24.94B | |
-21.03% | 18.96B | |
+28.82% | 12.3B | |
-2.30% | 11.95B | |
-1.52% | 11.55B |